At close: December 11 at 4:00:01 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 3 | 3 | 4 |
| Avg. Estimate | -0.19 | -0.2 | -0.91 | -0.71 |
| Low Estimate | -0.31 | -0.3 | -0.95 | -1.07 |
| High Estimate | -0.09 | -0.13 | -0.89 | -0.56 |
| Year Ago EPS | -0.22 | -0.29 | -1.14 | -0.91 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 7 | 7 |
| Avg. Estimate | 20.29M | 20M | 81.19M | 87.81M |
| Low Estimate | 19.9M | 19.48M | 80.7M | 85.81M |
| High Estimate | 21.2M | 20.44M | 82M | 91.88M |
| Year Ago Sales | 18.75M | 19.27M | 81.06M | 81.19M |
| Sales Growth (year/est) | 8.19% | 3.84% | 0.16% | 8.15% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.31 | -0.28 | -0.3 | -0.21 |
| EPS Actual | -0.22 | -0.29 | -0.25 | -0.22 |
| Difference | 0.09 | -0.01 | 0.05 | -0.01 |
| Surprise % | 28.66% | -2.76% | 15.32% | -6.52% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.19 | -0.2 | -0.91 | -0.71 |
| 7 Days Ago | -0.19 | -0.2 | -0.91 | -0.71 |
| 30 Days Ago | -0.19 | -0.18 | -0.91 | -0.71 |
| 60 Days Ago | -0.18 | -0.18 | -0.91 | -0.71 |
| 90 Days Ago | -0.18 | -0.18 | -0.91 | -0.71 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | 2 | 1 | 2 | 2 |
| Down Last 30 Days | 2 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SGHT | 14.20% | 31.95% | 19.97% | 22.20% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 12/11/2024 |
| Initiated | UBS: Buy | 12/6/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/11/2024 |
| Reiterates | Piper Sandler: Neutral to Neutral | 11/8/2024 |
| Reiterates | Needham: Hold | 11/8/2024 |
| Initiated | Lake Street: Buy | 8/21/2024 |
Related Tickers
RPID Rapid Micro Biosystems, Inc.
1.0100
-2.88%
CTKB Cytek Biosciences, Inc.
6.56
-2.53%
TMCI Treace Medical Concepts, Inc.
7.83
-0.89%
PEN Penumbra, Inc.
253.66
+4.70%
RXST RxSight, Inc.
37.58
-4.06%
IRTC iRhythm Technologies, Inc.
89.93
+3.49%
NVRO Nevro Corp.
4.3100
-0.69%
OFIX Orthofix Medical Inc.
18.54
-0.05%
LNSR LENSAR, Inc.
7.64
+0.92%
GKOS Glaukos Corporation
142.89
+4.77%